3,4-dihydrocoumarin has been researched along with rasagiline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, Y; Lan, JS; Liu, L; Liu, Y; Xie, SS; Yang, J; Yang, YT; Zeng, RF; Zhang, T | 1 |
1 other study(ies) available for 3,4-dihydrocoumarin and rasagiline
| Article | Year |
|---|---|
Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
Topics: Animals; Coumarins; Drug Design; Indans; Mice; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Oxidopamine; PC12 Cells; Protein Conformation; Rats; Rotenone; Structure-Activity Relationship | 2021 |